Transporting the AstraZeneca COVID 19 vaccine from PCN designated sites to end user locations , patients homes and within the PCN grouping
Regulatory Information
Regulatory approval of COVID-19 AstraZeneca vaccine
PGD for COVID-19 AstraZeneca vaccine
Patient Group Direction for COVID-19 AstraZeneca vaccine
PSD
Legal Mechanisms for adminstration of the covid-19 vaccines
National Protocol
National Protocol for Astra Zeneca COVID-19 Vaccine
Delivery
Dealing with delivery issues associated with the Covid-19 vaccines
Receipt
Receiving and storing the AstraZeneca COVID-19 vaccine
Stock Control
Stocktaking and reconciliation of the AstraZeneca COVID-19 Vaccine
Ordering
Ordering the AstraZeneca COVID-19 Vaccine by PCN designated sites
Preparation
Preparing the AstraZeneca COVID-19 Vaccine
Allergies
Advising individuals with allergies on their suitability for AstraZeneca C0vid 19 vaccine
Administration
https://www.sps.nhs.uk/articles/preparing-and-administering-the-astrazeneca-covid-19-vaccine/
Waste
Disposing of AstraZeneca COVID-19 Vaccine at PCN designated sites –
Housebound
Use of the covid-19 vaccine AstraZeneca to vaccinate housebound patients 11th Jan 2021
Position statement for vaccination of care home residents using COVID 19 vaccine AstraZeneca
The contents of this statement – recommends when planning vaccination sessions for care homes a primary care lead, pharmacist and lead GP at PCN designated site should complete an assessment to identify or understand risk factors associated with the transfer of the vaccine for the administration of remaining care home residents.
Primary Care COVID-19 Response Model